NEWS

What to Do When Your Lumbrokinase Test Result Differs From the Supplier COA The supplier Certificate of Analysis reports one Lumbrokinase activity result, but your independent laboratory reports another. This numerical difference deserves attention, but it does not automatically prove that the supplier result is incorrect, the laboratory made an...

How Supplement Companies Should Brief a Laboratory Before Testing Lumbrokinase Two Lumbrokinase activity numbers are not necessarily comparable simply because both were produced by laboratories. Before sending a raw-material sample for independent analysis, QA and R&D teams should define the testing objective, identify the sample, confirm the assay method and...

How Supplement Formulators Should Define a Lumbrokinase Ingredient Specification A supplier’s specification sheet describes the Lumbrokinase material that the supplier offers. It does not automatically establish what a supplement company should accept. Before approving an ingredient, formulation and QA teams need to determine what their own raw-material requirements should be....

Selecting Lumbrokinase powder for a capsule product involves more than choosing an activity number. Before formulation begins, product developers need to connect the raw-material specification and assay context with the practical requirements of blending, encapsulation, packaging and subsequent scale-up. A sound development process reviews technical documents, tests a representative sample...

Lumbrokinase incoming quality control begins when a commercial shipment reaches the buyer’s receiving location. At this point, supplier evaluation, sample testing, document review, and bulk-order approval have already taken place. The immediate objective is different: confirm that the material physically delivered corresponds to the approved order and is acceptable for...

When buyers search for pharmaceutical grade lumbrokinase, they are often looking for more than a standard product description. They may expect tighter specifications, clearer activity data, stronger batch control, a defined purity basis, and more complete technical documentation. However, “pharmaceutical-grade” should not be accepted as a standalone quality claim. Its...